R&D Bioanalytical labs need to reimagine data to streamline thei... The fundamental questions in the trial phases of drug development are “Does it work?”, “Is it safe?”, and “What else do we need to know?”
News NICE CEO to step down by year-end Sam Roberts is stepping down from the role of NICE CEO to support her children through a difficult time, and a search for her replacement is underway.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face